Free Trial

ClearPoint Neuro (CLPT) Stock Price, News & Analysis

ClearPoint Neuro logo
$10.49 0.00 (0.00%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$10.59 +0.10 (+0.94%)
As of 08/29/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ClearPoint Neuro Stock (NASDAQ:CLPT)

Key Stats

Today's Range
$10.31
$10.57
50-Day Range
$10.00
$12.24
52-Week Range
$9.76
$19.22
Volume
149,152 shs
Average Volume
381,591 shs
Market Capitalization
$298.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.67
Consensus Rating
Buy

Company Overview

ClearPoint Neuro Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

CLPT MarketRank™: 

ClearPoint Neuro scored higher than 41% of companies evaluated by MarketBeat, and ranked 687th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ClearPoint Neuro has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ClearPoint Neuro has only been the subject of 1 research reports in the past 90 days.

  • Read more about ClearPoint Neuro's stock forecast and price target.
  • Earnings Growth

    Earnings for ClearPoint Neuro are expected to grow in the coming year, from ($0.66) to ($0.59) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ClearPoint Neuro is -12.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ClearPoint Neuro is -12.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ClearPoint Neuro has a P/B Ratio of 15.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about ClearPoint Neuro's valuation and earnings.
  • Percentage of Shares Shorted

    9.06% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently increased by 14.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    ClearPoint Neuro does not currently pay a dividend.

  • Dividend Growth

    ClearPoint Neuro does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.06% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently increased by 14.01%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    ClearPoint Neuro has a news sentiment score of 1.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for ClearPoint Neuro this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for CLPT on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added ClearPoint Neuro to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ClearPoint Neuro insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $415,173.00 in company stock.

  • Percentage Held by Insiders

    Only 6.97% of the stock of ClearPoint Neuro is held by insiders.

  • Percentage Held by Institutions

    Only 30.08% of the stock of ClearPoint Neuro is held by institutions.

  • Read more about ClearPoint Neuro's insider trading history.
Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLPT Stock News Headlines

ClearPoint Neuro: Biopharma Momentum Continues To Build
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.tc pixel
ClearPoint Neuro Q2 2025 Earnings Preview
See More Headlines

CLPT Stock Analysis - Frequently Asked Questions

ClearPoint Neuro's stock was trading at $15.38 at the start of the year. Since then, CLPT stock has decreased by 31.8% and is now trading at $10.49.

ClearPoint Neuro, Inc. (NASDAQ:CLPT) issued its quarterly earnings data on Tuesday, August, 12th. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.20) by $0.01. The company had revenue of $9.22 million for the quarter, compared to analyst estimates of $9.20 million. ClearPoint Neuro had a negative trailing twelve-month return on equity of 94.44% and a negative net margin of 66.15%.
Read the conference call transcript
.

ClearPoint Neuro's top institutional investors include Geode Capital Management LLC (2.23%), Lane Generational LLC (0.92%), Taylor Frigon Capital Management LLC (0.64%) and Conway Capital Management Inc. (0.59%). Insiders that own company stock include Joseph Burnett and Timothy T Richards.
View institutional ownership trends
.

Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ClearPoint Neuro investors own include Arista Networks (ANET), NVIDIA (NVDA), CrowdStrike (CRWD), Axon Enterprise (AXON), Advanced Micro Devices (AMD), Cadence Design Systems (CDNS) and Broadcom (AVGO).

Company Calendar

Last Earnings
8/12/2025
Today
8/31/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CLPT
CIK
1285550
Employees
110
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$9.00
Potential Upside/Downside
+87.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.91 million
Net Margins
-66.15%
Pretax Margin
-66.11%
Return on Equity
-94.44%
Return on Assets
-51.58%

Debt

Debt-to-Equity Ratio
1.46
Current Ratio
7.30
Quick Ratio
6.45

Sales & Book Value

Annual Sales
$31.39 million
Price / Sales
9.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
15.20

Miscellaneous

Outstanding Shares
28,430,000
Free Float
26,446,000
Market Cap
$298.23 million
Optionable
Optionable
Beta
0.85

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CLPT) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners